An interventional study of lifestyle, PTA in Peripheral Vascular Disease, sponsored by Ullevaal University Hospital. Completed. Open to participants aged Up to 75 Days. Per ClinicalTrials.gov, last updated 2011-07-06.
Sponsored by Ullevaal University Hospital · Not applicable, Interventional, and Treatment
Background: Percutaneous transluminal angioplasty (PTA) has been popularized as a simple, effective and cheap treatment achieving 50-70% symptomatic patency rates in patients with peripheral occlusive disease.. However, the fact remains that the indication for performing PTA are still more based on opinions than on scientific data.
The purpose of the trial was to randomize patients primarily referred for intermittent claudication into two groups: One group was offered conservative treatment; the other group was offered conservative treatment combined with PTA.
Primary outcome: The patient quality of life. Secondary outcome:Pain-free walking distance; pain-score; death; amputation; changes in relevant biomarkers
1,027 studies on the registry are indexed under Vascular Diseases; 167 are open to participants now.
This study's enrollment of 200 is above the median of 78 across 639 interventional studies indexed under Vascular Diseases.
Browse Vascular Diseases studies →Ullevaal University Hospital is the lead sponsor of 76 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The patient quality of life.
Pain-free walking distance; pain-score; death; amputation; changes in relevant biomarkers
No study locations are listed for this record.
This study is completed, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ullevaal University Hospital